Consistent with above analysis, the S100A9 peptides were identified in all five groups (Supplementary Fig. 2c) and the number of identified S100A9 peptides were coordinately increased with tumor development stages in Brca1-MT mouse mammary tissues (Supplementary Fig. 2d). This evidence concerns the gene BRCA1 and neoplasm.